KRAS and neoplasm: A trend for decreased incidence of KRAS mutations in rectal tumors was observed (p = 0.097) since 31 of the 83 (37%) tumours located at the colon and six of the 29 (20%) tumours located at the rectum harbored a KRAS mutation.